Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 42571-247

This text appears to be showing a chart or table depicting Mean Ambulotory Systolic Blood Pressure (mmHg) readings at different time points post-dose administration. The data involves various measurements along with indications of hours post-dose and potential medication combinations, such as AML10/HCTZ25. Additionally, there seem to be references to baseline values and percentage changes related to different medication combinations. The information provided appears to be related to a study or experiment evaluating blood pressure dynamics under specific treatment conditions.*

This is a description for a medication tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide. Each film-coated tablet includes 20mg of olmesartan medoxomil, 6.9mg of amlodipine besylate (equivalent to 5mg of amlodipine), and 12.5mg of hydrochlorothiazide. The indicated usual dosage should be referred to the package insert. The tablets should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The NDC number is 42571-245-30 for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets in the strength of 20mg/5mg/12.5mg. This prescription medication is for oral use and comes in a package of 30 tablets. The tablets are manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc., based in Somerset, NJ. The latest revision date is May 2025, with a specific code provided for tracking purposes.*

This is a medication description for film-coated tablets containing 40 mg of olmesartan medoxomil, 6.9 mg of amlodipine besylate equivalent to 5 mg of amlodipine, and 12.5 mg of hydrochlorothiazide. The usual dosage information should be referred to the package insert. The tablets should be stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The product is identified by NDC 42571-246-30, containing 30 tablets. Manufactured by Micro Labs Limited in India and manufactured for Micro Labs USA, Inc. in Somerset, NJ. The code is GO/DRUGS/651 and the revision date is 05/2025.*

This is a description of a medication package containing film-coated tablets with a combination of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide. Each tablet consists of 40 mg olmesartan medoxomil, 6.9 mg amlodipine besylate (equal to 5 mg amlodipine), and 25 mg hydrochlorothiazide. The usual dosage information is available in the package insert. The tablets should be stored at 25°C with excursions permitted within the range of 15° to 30°C. The product is manufactured in India by Micro Labs Limited and distributed by Micro Labs USA, Inc. in Somerset, NJ.*

Each film-coated tablet contains 40 mg of olmesartan medoxomil and 13.9 mg of amlodipine besylate, equivalent to 10 mg of amlodipine. It also contains 12.5 mg of hydrochlorothiazide. The usual dosage information can be found in the package insert. Store the tablets at a temperature between 25°C to 30°C. This medication is manufactured for Micro Labs USA, Inc. in Somerset, NJ. The code for the tablets is GO/DRUGS/651.*

Each film-coated tablet contains 40 mg of olmesartan medoxomil USP, 13.9 mg of amlodipine besylate USP (equivalent to 10 mg of amlodipine), and 25 mg of Olmesartan Medoxomil, hydrochlorothiazide USP. The usual dosage should be referred to the package insert. The medication should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). This medication is manufactured for Micro Labs USA, Inc. in Somerset, NJ and comes in a pack of 30 tablets. Rev. 05/2025.*